ES2960326T3 - Extracto de Streptococcus uberis como agente inmunogénico - Google Patents

Extracto de Streptococcus uberis como agente inmunogénico Download PDF

Info

Publication number
ES2960326T3
ES2960326T3 ES17704038T ES17704038T ES2960326T3 ES 2960326 T3 ES2960326 T3 ES 2960326T3 ES 17704038 T ES17704038 T ES 17704038T ES 17704038 T ES17704038 T ES 17704038T ES 2960326 T3 ES2960326 T3 ES 2960326T3
Authority
ES
Spain
Prior art keywords
mastitis
biofilm
immunogenic agent
vaccine
uberis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17704038T
Other languages
English (en)
Spanish (es)
Inventor
Gimbert Rosa Maria Collado
I Amargos Antoni Prenafeta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hipra Scientific SL
Original Assignee
Hipra Scientific SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hipra Scientific SL filed Critical Hipra Scientific SL
Application granted granted Critical
Publication of ES2960326T3 publication Critical patent/ES2960326T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES17704038T 2016-02-15 2017-02-14 Extracto de Streptococcus uberis como agente inmunogénico Active ES2960326T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382060 2016-02-15
PCT/EP2017/053306 WO2017140683A2 (en) 2016-02-15 2017-02-14 Streptococcus uberis extract as an immunogenic agent

Publications (1)

Publication Number Publication Date
ES2960326T3 true ES2960326T3 (es) 2024-03-04

Family

ID=55646514

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17704038T Active ES2960326T3 (es) 2016-02-15 2017-02-14 Extracto de Streptococcus uberis como agente inmunogénico

Country Status (11)

Country Link
US (1) US10946085B2 (enExample)
EP (1) EP3417049B1 (enExample)
JP (1) JP6839199B2 (enExample)
KR (1) KR102824686B1 (enExample)
AU (1) AU2017220528A1 (enExample)
CA (1) CA3012419A1 (enExample)
ES (1) ES2960326T3 (enExample)
MX (1) MX387200B (enExample)
PL (1) PL3417049T3 (enExample)
WO (1) WO2017140683A2 (enExample)
ZA (1) ZA201805039B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022352157A1 (en) 2021-09-21 2024-05-02 National Agriculture And Food Research Organization Vaccine including nonencapsulated strain as antigen
EP4570265A1 (en) 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Vaccine for use in preventing inflammatory conditions in cows

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243024A (ja) * 1983-12-29 1985-12-03 Kitasato Inst:The ストレプトコツカス・サンギス感染症予防用ワクチン，診断用抗原および抗体
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2222701C (en) 1995-06-08 2012-02-07 University Of Saskatchewan Camp factor of streptococcus uberis
DK1332155T3 (da) 2000-06-12 2007-02-26 Univ Saskatchewan Vaccination af malkekvæg med GapC protein mod streptokokinfektion
US20070231335A1 (en) * 2005-07-20 2007-10-04 Bruce Beutler Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
US8273361B2 (en) 2006-09-26 2012-09-25 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20110028407A1 (en) * 2007-02-09 2011-02-03 Jutila Mark A Enhancement of innate resistance to infection
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
EP3461496B1 (en) * 2009-06-22 2023-08-23 Wyeth LLC Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
WO2012116447A1 (en) 2011-03-03 2012-09-07 The Governors Of The University Of Alberta Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
MX2013013182A (es) 2011-05-12 2013-12-09 Intervet Int Bv Tratamiento de la mastitis.
BR112013032675A2 (pt) * 2011-06-19 2017-08-08 Vaxine Pty Ltd composição adjuvante de vacina compreendendo partículas de inulina
WO2015042423A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Vaccine

Also Published As

Publication number Publication date
KR102824686B1 (ko) 2025-06-25
EP3417049A2 (en) 2018-12-26
PL3417049T3 (pl) 2024-02-19
CA3012419A1 (en) 2017-08-24
WO2017140683A2 (en) 2017-08-24
ZA201805039B (en) 2020-05-27
JP6839199B2 (ja) 2021-03-03
MX387200B (es) 2025-03-18
US20190038736A1 (en) 2019-02-07
MX2018009048A (es) 2019-03-28
KR20180108619A (ko) 2018-10-04
JP2019504623A (ja) 2019-02-21
AU2017220528A1 (en) 2018-08-09
EP3417049B1 (en) 2023-08-16
BR112018015255A2 (pt) 2018-12-18
WO2017140683A3 (en) 2017-10-12
US10946085B2 (en) 2021-03-16

Similar Documents

Publication Publication Date Title
Nordhaug et al. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters
Mukhopadhaya et al. Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition
US8778655B2 (en) Modified gram-negative bacteria for use as vaccines
JP2024175058A (ja) クロストリジウム・ディフィシル多成分ワクチン
JP2024540918A (ja) リポ多糖（ｌｐｓ）欠損アシネトバクター・バウマニ多価ワクチン
Angelos Moraxella
ES2960326T3 (es) Extracto de Streptococcus uberis como agente inmunogénico
Aoki et al. Stationary phase culture supernatant containing membrane vesicles induced immunity to rainbow trout Oncorhynchus mykiss fry syndrome
Riottot et al. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations
US5429818A (en) Non-capsulated mutants of Actinobacillus pleuropneumoniae useful as vaccines
KR101588297B1 (ko) 액티노바실루스 플로르뉴모니애, 파스튜렐라 멀토시다 및 써코바이러스에 의한 돼지의 감염을 예방하거나 치료하기 위한 다가 백신 조성물
Nedbalcova et al. Passive immunisation of post-weaned piglets using hyperimmune serum against experimental Haemophilus parasuis infection
Donachie Vaccine development against Pasteurella haemolytica infections in sheep
Dellagostin et al. TbpBY167A-based vaccine is safe in pregnant sows and induces high titers of maternal derived antibodies that reduce Glaesserella parasuis colonization in piglets
JP2024529055A (ja) Ｃｌｏｓｔｒｉｄｉｕｍ ｃｈａｕｖｏｅｉワクチン及び作製方法
CN102740878A (zh) 链球菌组合疫苗
BR112018015255B1 (pt) Processo para a preparação de um agente imunogênico, vacina, kit de vacinação e uso de um biofilme tratado termicamente com calor
JPH11240844A (ja) 肺炎球菌抗原の経口投与
KR100258772B1 (ko) 돼지의 흉막폐염 백신 조성물
RU2589819C1 (ru) ВАКЦИНА ПРОТИВ ИНФЕКЦИОННОГО КЕРАТОКОНЪЮНКТИВИТА КРУПНОГО РОГАТОГО СКОТА НА ОСНОВЕ АНТИГЕНОВ БАКТЕРИЙ Moraxella bovis И Moraxella bovoculi
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
JP2020522471A (ja) クロストリジウム類毒素を含むワクチン
BRPI1003753A2 (pt) composiÇÕes imunogÊnicas sinÉrgicas baseadas em antÍgenos protÉicos combinados com antÍgeno celular pertussis e toxinas inativadas
Linde et al. Prophylaxis of Salmonella (S.) abortus ovis caused abortions of sheep by a S. typhimurium live vaccine
PT103450B (pt) Vacina contra streptococcus agalactiae usando como antigénio alvo a proteína gliceraldeído-3-fosfato desidrogenase (gapdh) produzida pela bactéria, na sua forma nativa ou recombinante